Evaluation of lipoprotein(a) and genetic prothrombotic risk factors in patients with recurrent foetal loss.
Nowak-Göttl
U
U
Sonntag
B
B
Junker
R
R
Cirkel
U
U
von Eckardstein
A
A
D000328:Adult; D005165:Factor V / Q000009:adverse effects / Q000235:genetics; D005260:Female; D005313:Fetal Death / Q000097:blood / Q000453:epidemiology / Q000235:genetics*; D006801:Humans; D017270:Lipoprotein(a) / Q000009:adverse effects / Q000097:blood / Q000235:genetics*; D016555:Matched-Pair Analysis; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP) / Q000009:adverse effects / Q000235:genetics; D017354:Point Mutation; D011110:Polymorphism, Genetic; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000453:epidemiology; D011261:Pregnancy Trimester, First; D015995:Prevalence; D011516:Prothrombin / Q000009:adverse effects / Q000235:genetics; D012008:Recurrence; D012307:Risk Factors; D019851:Thrombophilia / Q000097:blood / Q000453:epidemiology / Q000235:genetics*; D044465:White People / Q000235:genetics
D017270:Lipoprotein(a); D005165:Factor V; D011516:Prothrombin; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP)